[SARS-CoV-2, a new causal agent of Guillain-Barre syndrome]

Rev Neurol. 2020 Oct 1;71(7):275-276. doi: 10.33588/rn.7107.2020264.
[Article in Spanish]

Abstract

SARS-CoV-2, nuevo agente causal del síndrome de Guillain-Barré.

Publication types

  • Case Reports
  • Letter

MeSH terms

  • Antibodies, Viral / blood
  • Betacoronavirus / immunology
  • Betacoronavirus / isolation & purification
  • Betacoronavirus / pathogenicity*
  • COVID-19
  • COVID-19 Testing
  • Causality
  • Clinical Laboratory Techniques
  • Coronavirus Infections / complications*
  • Coronavirus Infections / diagnosis
  • Coronavirus Infections / epidemiology
  • Female
  • Guillain-Barre Syndrome / diagnosis
  • Guillain-Barre Syndrome / etiology*
  • Guillain-Barre Syndrome / virology
  • Humans
  • Immunoglobulin G / blood
  • Immunoglobulin M / blood
  • Middle Aged
  • Neural Conduction
  • Oropharynx / virology
  • Pandemics*
  • Pneumonia, Viral / complications*
  • Pneumonia, Viral / epidemiology
  • Real-Time Polymerase Chain Reaction
  • SARS-CoV-2

Substances

  • Antibodies, Viral
  • Immunoglobulin G
  • Immunoglobulin M